Literature DB >> 24675629

Construction of a reusable, high-fidelity model to enhance extracorporeal membrane oxygenation training through simulation.

Jess L Thompson1, Lisa M Grisham, Jeanne Scott, Chris Mogan, Hannes Prescher, David Biffar, John Jarred, Robyn J Meyer, Allan J Hamilton.   

Abstract

Initiation of extracorporeal membrane oxygenation (ECMO) is stressful, especially for inexperienced extracorporeal life support providers. The main objective of this study was to create a novel, reusable mannequin for high-fidelity simulation of ECMO initiation. We modified a Laerdal neonatal mannequin (SimNewB; Stavanger, Norway) so that it could be used to simulate an ECMO initiation. A simulation of a neonatal patient suffering from meconium aspiration was performed in the pediatric intensive care unit, and participants included new extracorporeal life support specialists in addition to the composition of the clinical ECMO team. A total of 17 individuals participated in the neonatal ECMO initiation simulation. Questionnaire results showed that 88% of participants felt better prepared to assist in an ECMO initiation after the simulation. All participants (100%) agreed that the modified mannequin and the environment were realistic and that this simulation helps teamwork and communication in future initiations of ECMO. Simulation can be used for the prevention, identification, and reduction of anxiety-related crisis situations that novice providers may infrequently encounter during routine clinical use of mechanical circulatory support. Use of a reusable, high-fidelity mannequin may be beneficial for effective team training of complex pediatric ECMO-related procedures.

Entities:  

Mesh:

Year:  2014        PMID: 24675629     DOI: 10.1097/ANC.0000000000000054

Source DB:  PubMed          Journal:  Adv Neonatal Care        ISSN: 1536-0903            Impact factor:   1.968


  1 in total

1.  Simulation-based training for handling extracorporeal membrane oxygenation emergencies.

Authors:  Shingo Sakamoto
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.